Colgate-Palmolive Company $CL Shares Acquired by Howard Capital Management LLC

Howard Capital Management LLC increased its holdings in Colgate-Palmolive Company (NYSE:CL) by 140.5% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 12,062 shares of the company’s stock after purchasing an additional 7,047 shares during the period. Howard Capital Management LLC’s holdings in Colgate-Palmolive were worth $1,029,000 at the end of the most recent reporting period.

A number of other large investors have also recently bought and sold shares of the business. Annex Advisory Services LLC lifted its position in shares of Colgate-Palmolive by 136.1% in the third quarter. Annex Advisory Services LLC now owns 13,604 shares of the company’s stock worth $1,161,000 after buying an additional 7,843 shares during the last quarter. NFSG Corp increased its holdings in shares of Colgate-Palmolive by 831.3% during the 3rd quarter. NFSG Corp now owns 6,221 shares of the company’s stock valued at $531,000 after acquiring an additional 5,553 shares during the last quarter. V Square Quantitative Management LLC increased its holdings in shares of Colgate-Palmolive by 5.2% during the 3rd quarter. V Square Quantitative Management LLC now owns 19,591 shares of the company’s stock valued at $1,672,000 after acquiring an additional 968 shares during the last quarter. Cohen Klingenstein LLC increased its holdings in shares of Colgate-Palmolive by 9.0% during the 3rd quarter. Cohen Klingenstein LLC now owns 167,669 shares of the company’s stock valued at $14,306,000 after acquiring an additional 13,870 shares during the last quarter. Finally, Barlow Wealth Partners LLC raised its stake in shares of Colgate-Palmolive by 11.9% in the 3rd quarter. Barlow Wealth Partners LLC now owns 7,309 shares of the company’s stock valued at $624,000 after acquiring an additional 775 shares in the last quarter. 80.41% of the stock is currently owned by institutional investors.

Colgate-Palmolive Trading Up 1.5%

Shares of Colgate-Palmolive stock opened at $94.02 on Friday. The company’s fifty day simple moving average is $89.05 and its 200-day simple moving average is $89.02. The company has a market cap of $74.95 billion, a price-to-earnings ratio of 37.31, a PEG ratio of 4.50 and a beta of 0.33. The company has a current ratio of 1.03, a quick ratio of 0.67 and a debt-to-equity ratio of 13.82. Colgate-Palmolive Company has a 1 year low of $74.54 and a 1 year high of $99.33.

Colgate-Palmolive (NYSE:CL) last announced its earnings results on Friday, July 31st. The company reported $0.99 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.95 by $0.04. The business had revenue of $5.36 billion for the quarter, compared to analyst estimates of $5.36 billion. Colgate-Palmolive had a net margin of 9.68% and a return on equity of 464.63%. Colgate-Palmolive’s revenue was up 4.9% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.92 earnings per share. As a group, sell-side analysts expect that Colgate-Palmolive Company will post 3.87 EPS for the current year.

Colgate-Palmolive Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, November 13th. Shareholders of record on Tuesday, October 20th will be given a $0.53 dividend. This represents a $2.12 annualized dividend and a yield of 2.3%. The ex-dividend date is Tuesday, October 20th. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 84.13%.

Wall Street Analyst Weigh In

Several research firms recently weighed in on CL. Deutsche Bank Aktiengesellschaft restated a “buy” rating and issued a $101.00 target price (up from $99.00) on shares of Colgate-Palmolive in a report on Monday, August 3rd. Sanford C. Bernstein reiterated a “market perform” rating on shares of Colgate-Palmolive in a report on Thursday, August 13th. TD Cowen increased their price target on Colgate-Palmolive from $85.00 to $90.00 and gave the company a “hold” rating in a report on Monday, August 3rd. Weiss Ratings lowered shares of Colgate-Palmolive from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Friday, October 2nd. Finally, BNP Paribas Exane reduced their price objective on shares of Colgate-Palmolive from $101.00 to $97.00 and set an “outperform” rating for the company in a research note on Monday, September 28th. Thirteen analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $97.95.

Insider Transactions at Colgate-Palmolive

In other news, Director John Cahill sold 4,170 shares of the company’s stock in a transaction dated Thursday, August 6th. The shares were sold at an average price of $93.37, for a total transaction of $389,352.90. Following the completion of the transaction, the director owned 28,373 shares of the company’s stock, valued at approximately $2,649,187.01. This represents a 12.81% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Noel Wallace sold 161,021 shares of the stock in a transaction dated Tuesday, August 4th. The shares were sold at an average price of $91.92, for a total transaction of $14,801,050.32. Following the completion of the sale, the chief executive officer owned 362,231 shares of the company’s stock, valued at approximately $33,296,273.52. The trade was a 30.77% decrease in their position. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last 90 days, insiders have sold 175,191 shares of company stock worth $16,110,903. 0.43% of the stock is currently owned by company insiders.

Colgate-Palmolive Profile

Colgate-Palmolive Company (NYSE: CL) is a global consumer products company focused on oral care, personal care, home care and pet nutrition. Its portfolio includes toothpaste, toothbrushes, mouthwash, liquid hand soap, body wash, deodorants, household cleaning products and pet food and treats.

The company markets well-known brands such as Colgate, Palmolive, elmex, meridol, Softsoap, Irish Spring, Ajax, Protex and Hill’s Science Diet. Colgate-Palmolive also provides veterinary and nutritional products through Hill’s Pet Nutrition, which serves pet owners and animal health professionals.

Founded in 1806 by William Colgate, the company developed from a soap and candle business into a diversified consumer goods manufacturer.